StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BAX

Baxter International Inc.

BAX NYSE Surgical & Medical Instruments & Apparatus EDGAR ↗
$28.10
+1.35 +5.05%

Key statistics

from XBRL data in SEC filings
Market cap
$14.5B
Revenue (TTM)
$11.5B
Net income (TTM)
-$1.06B
EPS (TTM)
$-2.09
P/E ratio
Dividend yield
0.71%
Free cash flow
$332M
Cash
$2.15B
Total assets
$19.8B
Gross margin
30.1%
52-week range
$15.73 – $30.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release); Other events Jul 30, 2026 8-K Regulation FD disclosure Jul 14, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results May 8, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release); Other events Apr 30, 2026 8-K Regulation FD disclosure Mar 19, 2026 8-K Director or officer change; Regulation FD disclosure Mar 16, 2026 10-K Fiscal year ended 2025-12-31 Feb 12, 2026 8-K Results of operations (earnings release); Director or officer change; Other events Feb 12, 2026 8-K Other events Dec 22, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Other events Dec 4, 2025 8-K Entered a material agreement Nov 25, 2025 8-K Other events Nov 19, 2025 8-K Other events Nov 19, 2025 8-K Director or officer change Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Director or officer change Oct 21, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Jul 31, 2025 8-K Director or officer change; Regulation FD disclosure Jul 7, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Jun 12, 2025 8-K Shareholder vote results May 8, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 1, 2025 8-K Regulation FD disclosure Mar 14, 2025 10-K Fiscal year ended 2024-12-31 Feb 21, 2025 8-K Results of operations (earnings release) Feb 20, 2025 8-K/A Regulation FD disclosure Feb 6, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Feb 3, 2025 8-K Completed an acquisition or disposition; Director or officer change Feb 3, 2025 8-K Director or officer change Jan 31, 2025 8-K Amended charter or bylaws Nov 27, 2024 8-K Director or officer change Nov 22, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 8, 2024 8-K Regulation FD disclosure Nov 7, 2024 8-K Regulation FD disclosure Oct 9, 2024 8-K Regulation FD disclosure Sep 30, 2024